G8873 – Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)

Long description

Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)

Short description

Specimen not intraop image

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

M5B Specialist - psychiatry

Added

January 1, 2012

Last change

January 1, 2021 – No change

Termination date

December 31, 2020

Nearby G codes

• G8865 – Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)
• G8866 – Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)
• G8867 – Pneumococcal vaccine not administered or previously received, reason not given
• G8868 – Patients receiving a first course of anti-tnf therapy
• G8869 – Patient has documented immunity to hepatitis b and initiating anti-tnf therapy
• G8870 – Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy
• G8871 – Patient not receiving a first course of anti-tnf therapy
• G8872 – Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
• G8874 – Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion
• G8875 – Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
• G8876 – Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)
• G8877 – Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given
• G8878 – Sentinel lymph node biopsy procedure performed
• G8879 – Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer
• G8880 – Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)
• G8881 – Stage of breast cancer is greater than t1n0m0 or t2n0m0